These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 19572232)

  • 61. The novel WHO 2010 classification for gastrointestinal neuroendocrine tumours correlates well with the metastatic potential of rectal neuroendocrine tumours.
    Jernman J; Välimäki MJ; Louhimo J; Haglund C; Arola J
    Neuroendocrinology; 2012; 95(4):317-24. PubMed ID: 22327359
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Immunohistochemical expression and prognostic value of ER, PR and HER2/neu in pancreatic and small intestinal neuroendocrine tumors.
    Arnason T; Sapp HL; Barnes PJ; Drewniak M; Abdolell M; Rayson D
    Neuroendocrinology; 2011; 93(4):249-58. PubMed ID: 21487213
    [TBL] [Abstract][Full Text] [Related]  

  • 63. [Clinicopathologic characteristics of 127 cases of gastroenteropancreatic neuroendocrine tumors (GEP-NETs) studied in an oncology hospital].
    Alvarado-Cabrero I; de Anda-González J; Hernández-Hernández B; Mantilla-Morales A; Valencia-Cedillo R; Medrano-Guzmán R
    Rev Gastroenterol Mex; 2012; 77(4):174-80. PubMed ID: 23142406
    [TBL] [Abstract][Full Text] [Related]  

  • 64. [Neuroendocrine tumors of the gastroenteropancreatic system--reevaluation using the Capella classification].
    Brüwer M; Pahlov-Nejad T; Herbst H; Senninger N; Schürmann G
    Zentralbl Chir; 2003 Aug; 128(8):656-62. PubMed ID: 12931261
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Treatment of small intestinal neuroendocrine tumors: is an extended multimodal approach justified?
    Schindl M; Kaczirek K; Passler C; Kaserer K; Prager G; Scheuba C; Raderer M; Niederle B
    World J Surg; 2002 Aug; 26(8):976-84. PubMed ID: 12016477
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Survival in neuroendocrine neoplasms; A report from a large Norwegian population-based study.
    Boyar Cetinkaya R; Aagnes B; Myklebust TÅ; Thiis-Evensen E
    Int J Cancer; 2018 Mar; 142(6):1139-1147. PubMed ID: 29082524
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Relevant prognostic factors in patients with stage IV small intestine neuroendocrine neoplasms.
    Maurer E; Heinzel-Gutenbrunner M; Rinke A; Rütz J; Holzer K; Figiel J; Luster M; Bartsch DK
    J Neuroendocrinol; 2022 Jan; 34(1):e13076. PubMed ID: 34964186
    [TBL] [Abstract][Full Text] [Related]  

  • 68. IMP3 expression in small-intestine neuroendocrine neoplasms: a new predictor of recurrence.
    Massironi S; Del Gobbo A; Cavalcoli F; Fiori S; Conte D; Pellegrinelli A; Milione M; Ferrero S
    Endocrine; 2017 Nov; 58(2):360-367. PubMed ID: 28210937
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Midgut neuroendocrine tumours with liver metastases: results of the UKINETS study.
    Ahmed A; Turner G; King B; Jones L; Culliford D; McCance D; Ardill J; Johnston BT; Poston G; Rees M; Buxton-Thomas M; Caplin M; Ramage JK
    Endocr Relat Cancer; 2009 Sep; 16(3):885-94. PubMed ID: 19458024
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Long-term results of surgery for small intestinal neuroendocrine tumors at a tertiary referral center.
    Norlén O; Stålberg P; Öberg K; Eriksson J; Hedberg J; Hessman O; Janson ET; Hellman P; Åkerström G
    World J Surg; 2012 Jun; 36(6):1419-31. PubMed ID: 21984144
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Incidence, patterns of care and prognostic factors for outcome of gastroenteropancreatic neuroendocrine tumors (GEP-NETs): results from the National Cancer Registry of Spain (RGETNE).
    Garcia-Carbonero R; Capdevila J; Crespo-Herrero G; Díaz-Pérez JA; Martínez Del Prado MP; Alonso Orduña V; Sevilla-García I; Villabona-Artero C; Beguiristain-Gómez A; Llanos-Muñoz M; Marazuela M; Alvarez-Escola C; Castellano D; Vilar E; Jiménez-Fonseca P; Teulé A; Sastre-Valera J; Benavent-Viñuelas M; Monleon A; Salazar R
    Ann Oncol; 2010 Sep; 21(9):1794-1803. PubMed ID: 20139156
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Peritoneal carcinomatosis from small intestinal neuroendocrine tumors: Clinical course and genetic profiling.
    Norlén O; Edfeldt K; Akerstrom G; Westin G; Hellman P; Bjorklund P; Stalberg P
    Surgery; 2014 Dec; 156(6):1512-21; discussion 1521-2. PubMed ID: 25456945
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Palliative resection of primary site in advanced gastroenteropancreatic neuroendocrine tumors improves survivals.
    Kıvrak Salim D; Bayram S; Gömceli İ; Çekin AH; Karaca M; Koçer M; Yıldız M
    Turk J Gastroenterol; 2019 Oct; 30(10):910-916. PubMed ID: 31625933
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Gastroenteropancreatic neuroendocrine tumors: 10-year experience in a single center.
    Yildiz O; Ozguroglu M; Yanmaz T; Turna H; Serdengecti S; Dogusoy G
    Med Oncol; 2010 Dec; 27(4):1050-6. PubMed ID: 19908171
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Neuroendocrine Gastroenteropancreatic Tumors: Where Are We?
    Ulla Rocha JL; Salgado A; Sardina Ferreiro R; Fernandez Catalina P; Gallardo E
    Surg Laparosc Endosc Percutan Tech; 2017 Feb; 27(1):36-41. PubMed ID: 27977507
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Exploring the rising incidence of neuroendocrine tumors: a population-based analysis of epidemiology, metastatic presentation, and outcomes.
    Hallet J; Law CH; Cukier M; Saskin R; Liu N; Singh S
    Cancer; 2015 Feb; 121(4):589-97. PubMed ID: 25312765
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Mesenteric Tumor Deposits in Midgut Small Intestinal Neuroendocrine Tumors Are a Stronger Indicator Than Lymph Node Metastasis for Liver Metastasis and Poor Prognosis.
    Fata CR; Gonzalez RS; Liu E; Cates JM; Shi C
    Am J Surg Pathol; 2017 Jan; 41(1):128-133. PubMed ID: 27684993
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Prognostic significance of Chromogranin A in small pancreatic neuroendocrine tumors.
    Raoof M; Jutric Z; Melstrom LG; Lee B; Li D; Warner SG; Fong Y; Singh G
    Surgery; 2019 Apr; 165(4):760-766. PubMed ID: 30447803
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Bone metastases in well-to-moderately differentiated neuroendocrine tumors: a single institutional review from the Ohio State University Medical Center.
    Kavecansky J; Wei L; Caronia L; Ramirez MT; Bloomston M; Shah MH
    Pancreas; 2015 Mar; 44(2):198-203. PubMed ID: 25411805
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Survival and disease recurrence in patients operated for small intestinal neuroendocrine tumors at a referral hospital.
    Folkestad O; Wasmuth HH; Mjønes P; Fougner R; Hauso Ø; Fossmark R
    Surg Oncol; 2020 Dec; 35():336-343. PubMed ID: 32979699
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.